MLX-4000

N/A

Report date: 2024/09/02 10:00:15
NMEFirst In Class

Base Information

Drug NameMLX-4000
Drug Alias NameMLX-4000MLX 4000BLX 4000BLX-4000
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTRAF2 and NCK-interacting protein kinase inhibitors
TargetsTRAF2 and NCK-interacting protein kinase
Therapy Area/IndicationsObesityDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBiolexis Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesBiolexis Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsObesityDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A